Evidence map›Paper›PMID 27982498›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2017

Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?

Antoni Bayés de Luna, Adrian Baranchuk, Manuel Martínez-Sellés, Pyotr G Platonov

Open access · greenAbstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Electrocardiographic Indicators of Left Atrial Remodeling in Ischemic Stroke Patients with Atrial Fibrillation.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Beyond CHAEuropean heart journal supplements : journal of the European Society of Cardiology · 2020
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Atrial fibrillation in the elderly.Journal of geriatric cardiology : JGC · 2017
    Article
  12. Article
  13. Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2017
    Article
  14. Article
  15. [Bayés Syndrome, Stroke and Dementia].Archivos peruanos de cardiologia y cirugia cardiovascular
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Antoni Bayés de LunaCatalan Institute of Cardiovascular Sciences, St. Pau Hospital, Barcelona, Spain.
Adrian BaranchukHeart Rhythm Service, Kingston General Hospital, Queen's University, Kingston, ON, Canada.
Manuel Martínez-SellésCardiology Department, Hospital Universitario Gregorio Marañón, Universidad Europea, Universidad Complutense, Madrid, Spain.
Pyotr G PlatonovCenter for Integrative Electrocardiology at Lund University (CIEL), and Arrhythmia Clinic Sweden, Skåne University Hospital, Lund, Sweden.
Hospital General Universitario Gregorio Marañón · ESKingston General Hospital · CASkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is currently considered a risk factor for stroke. Depending on the severity of clinical factors (risk scores) a recommendation for full anticoagulation is made. Although AF is most certainly a risk factor for ischemic stroke, it is not necessarily the direct cause of it. The causality of association between AF and ischemic stroke is questioned by the reported lack of temporal relation between stroke events and AF paroxysms (or atrial high-rate episodes detected by devices). In different studies, only 2% of patients had subclinical AF > 6 minutes in duration at the time of stroke or systemic embolism. Is it time to consider AF only one more factor of endothelial disarray rather than the main contributor to stroke? In this "opinion paper" we propose to consider not only clinical variables predicting AF/stroke but also electrocardiographic markers of atrial fibrosis, as we postulate this as a strong indicator of risk of AF/stroke. We ask if it is time to change the paradigm and to consider, in some special situations, to protect patients (preventing stroke) who have no evidence of AF.

Indexed as

AnticoagulantsAtrial FibrillationHumansRisk AssessmentRisk FactorsStrokeAnticoagulants

Identifiers

PMID27982498
PMCPMC6931884
OpenAlexW2563309972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.